Elizabeth G. O'Farrell
Independent Chairman of the BoardMs. Elizabeth G. O'Farrell, also known as Liz, is Director at Karius, Inc. since August 2023. She has been Chairman of the Board at Geron Corporation and is its Independent Director since March 26, 2019 and had been its Lead Independent Director since May 31, 2023. Ms. O'Farrell has been an Independent Director of PDL BioPharma, Inc. since June 22, 2018 and serves as its Chairperson of the Board since January 1, 2020. Ms. O'Farrell served as the Chief Procurement Officer and Global Head of Shared Services at Eli Lilly and Company from January 2012 to December 2017 and served as its Senior Vice President, Finance; Senior Vice President of policy and finance and Controller from August 2008 to June 2011. Ms. O'Farrell served as Director of Human Resources at Bay Equity LLC. Ms. O'Farrell served as a Senior Vice President and Director of Human Resources at Bank of Marin BanCorp. She served as the Chief Financial Officer for Lilly USA since June 2006. She served as the General Auditor, the Director of Corporate Services and Chief Financial Officer of Eli Lilly Canada. Currently, she serves on the board of directors of Genmab A/S. Additionally, Ms. O’Farrell previously served on the board of directors for Inhibikase Therapeutics, Inc. (Nasdaq: IKT) from April 2019 to September 2022. In this role, she was responsible for Finance, Information Technology and Logistics. She was also a member of the Senior Management Team of Eli Lilly Canada. She served as the Manager of Corporate Financial Reporting at Eli Lilly’s head office in Indianapolis, Indiana. Since joining Lilly in 1993, Ms. O'Farrell has held a number of progressive assignments within the financial division including Project Leader, Financial Systems and Department Head of Payroll Disbursements. Before joining Eli Lilly, Ms. O'Farrell was an Accountant with Boise Cascade Office Products and served as an Auditor at Whipple & Company Corporation and Price Waterhouse. She began her career in public accounting with Price Waterhouse and was a Manager with Somerset Financial prior to joining Lilly. She had been an Independent Director of Inhibikase Therapeutics, Inc since December 22, 2020 until September 1 2022 and She is an Independent Director of LENSAR, Inc. since February 2021. Ms. O'Farrell was an active board member of the YMCA of Greater Indianapolis for more than a decade and served as its Chair from 2014 to 2016. She served as an Executive Director for Lilly USA since June 2006. She served as an Executive Director of Eli Lilly Canada until 2017. She is also a member of the Finance Committee of the United Way of Brevard (Brevard County, Fla.) and previously served on the boards of the Washington Township Schools Foundation and Keep Indianapolis Beautiful. She received her CPA license in 1991. Ms. O'Farrell holds a BS in accounting with honors and an MBA in management information systems from Indiana University in 1987, where she also earned a BS in Accounting in 1986.
Positions
- Company NameGeron CorporationStock CodeGERNPositionIndependent Chairman of the BoardColleagues
- HSHarout SemerjianCEO, President & Director
- MJMichelle J. RobertsonEVP, CFO, Treasurer and Principal Financial & Accounting Officer
- JEJoseph Emile EidExecutive VP of Research & Development and Chief Medical Officer
- AEAhmed ElNawawiExecutive VP & Chief Commercial Officer
- STShanthakumar TyavanagimattSenior VP & Chief Technical Officer
- SMSusan M. MolineauxIndependent Director
- DCDawn Carter BirIndependent Director
- RJRobert Jay SpiegelIndependent Director
- Company NameLENSAR, Inc.Stock CodeLNSRPositionIndependent DirectorColleagues
- NTNicholas T. CurtisPresident, CEO & Director
- WJWilliam J. LinkIndependent Chairman
- ABAlan B. ConnaughtonChief Operating Officer
- MAMichael A. RossiInterim CFO & Principal Financial Officer and Secretary
- KWKendra W. WongPrincipal Accounting Officer
- RLRichard L. LindstromIndependent Director
- GMGary M. WinerIndependent Director
- EGElizabeth G. O'FarrellIndependent Director
